Finally, we observed a statistically significant increase in TIM3+ T cells in PeptiCRAd-treated mice compared to the controls, along with a more pronounced PD1+/TIM3+ double-positive T cell population in PeptiCRAd-treated mice (Supplementary Fig. 9C), aligning with the observations made in the tumor milieu. Here, HAVCR2 is linked to neoplasm.